Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

First-in-human study tests BI-764524 in diabetic macular ischemia

July 2, 2020

Enspryng approved in Japan for adults and children with NMOSD

June 30, 2020

ReNeuron reports further data from phase IIa study of hRPC stem cell therapy candidate in RP

June 29, 2020

FDA issues complete response letter for abicipar pegol in wet AMD

June 26, 2020

Opthea reports phase IIa topline data on OPT-302 for refractory DME

June 10, 2020

Nicox's NCX-470 enters phase III development

June 2, 2020

Ocugen discontinues phase III trial of OCU-300 for ocular graft-versus-host disease

June 2, 2020

Phase III Archway study of Port Delivery System with ranibizumab in wet AMD meets primary endpoint

May 27, 2020

Theravance Biopharma identifies JAK inhibitors

May 20, 2020

ELX-01 shows functional activity in a model of nonsense mutation-related IRD

May 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...